Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
07/2001
07/04/2001EP1112251A1 Azetidine derivatives, preparation and medicines containing them
07/04/2001EP1112071A1 Growth hormone secretagogues
07/04/2001EP1112070A1 Novel substituted triazole compounds
07/04/2001EP0850236B1 Piperazino derivatives as neurokinin antagonists
07/04/2001CN1302296A Novel 2-alkyl substituted imidazole compounds
07/04/2001CN1301699A New direct chain or cyclic urea, its preparing method and medicinal composition containing them
07/04/2001CN1068028C Reactive dyes, processes for their preparation and their use
07/04/2001CN1067999C Anti-helicobacter heterocyclic derivatives of azolines
07/04/2001CN1067998C Hydrate for medicinal use
07/04/2001CN1067992C Substituted thiazolidine derivatives and pharmaceutical compounds containing them and use thereof
07/04/2001CN1067986C 1H-indole-3-acetic acid hydrazide phospholipid enzyme A2 inhibitors
07/03/2001US6255495 Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups and method of application thereof
07/03/2001US6255494 Substituted benzimidazoles useful in treating or preventing conditions associated with excess of neuropeptide y (around arteries in heart, respiratory tract, gastrointestinal tract and genitourinary tract); etiology of psychiatric disorders
07/03/2001US6255491 Synthesis of intermediate compounds for 4-adyl-5-pyrimidine imidazole substituted derivatives
07/03/2001US6255342 Pesticides
07/03/2001US6255334 5HT 1 receptor agonists and metoclopramide for the treatment of migraine
07/03/2001US6255333 Humans or animals
07/03/2001US6255315 Alpha 1a adrenergic receptor antagonists
07/03/2001US6255091 Potentiating metal mediated serine protease inhibitors with cobalt or zinc ions
07/03/2001CA2216231C Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
07/03/2001CA2037630C Nitrogen-containing heterocylic compounds, their production and use
06/2001
06/29/2001CA2328775A1 4-oxo-2-ureido-1,4,5,6-tetrahydro-pyrimidine derivatives
06/28/2001WO2001046200A1 Novel piperidine and piperazine derivatives
06/28/2001WO2001046189A1 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
06/28/2001WO2001046178A2 Substituierte bisindolymaleimide
06/28/2001WO2001046157A1 Benzo[a]phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase i and ii
06/28/2001WO2001046156A1 Butyne diol derivatives
06/28/2001WO2001046140A1 Ep4 receptor selective agonists in the treatment of osteoporosis
06/28/2001WO2001045700A1 Urotensin-ii receptor antagonists
06/28/2001WO2001045689A2 Indolinone derivatives for modulation of c-kit tyrosine protein kinase
06/28/2001WO2001045637A2 Novel 4(piperazinyl (8-quinolinyl)metyl)benzamides
06/28/2001DE19962329A1 New substituted 2-(phenylaminomethyl)-benzimidazoles, used as thrombin inhibitors, serine protease inhibitors, antithrombotic agents and intermediates
06/28/2001CA2394852A1 Substituted pyrroles
06/28/2001CA2394095A1 Novel piperidine and piperazine derivatives
06/28/2001CA2392873A1 Benzo[a]phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase i and ii
06/28/2001CA2389479A1 Butyne diol derivatives
06/27/2001EP1110957A1 Benzazole derivatives and their use as JNK modulators
06/27/2001EP1110954A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
06/27/2001EP1110953A1 Quinazoline derivatives
06/27/2001EP1110952A1 Carboxylic acid derivates, their preparation and use
06/27/2001EP1110949A1 EP4 receptor selective agonists in the treatment of osteoporosis
06/27/2001EP1110945A2 Azocompounds for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
06/27/2001EP1110556A1 Preventives/remedies for multiple organ failure
06/27/2001EP1110551A2 Ocular tension lowering agent
06/27/2001EP1110453A1 Triazolyloxybenzyl alkoxyacrylic acid esters, process for producing them and their use
06/27/2001EP1109803A1 Substituted imidazoles having cytokine inhibitory activity
06/27/2001EP1109790A1 1, 2, 4-triazole-3-thione compounds
06/27/2001EP1109785A2 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation
06/27/2001EP1109580A1 Methods for treating or preventing viral infections and associated diseases
06/27/2001EP1109555A1 Novel angiogenesis inhibitors
06/27/2001EP1109550A2 Novel nitrophenylaziridine compounds and their use as prodrugs
06/27/2001EP1109543A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
06/27/2001EP0824518B1 (het)aryloxy-, -thio-, aminocrotonates, methods of preparing them and their use as insecticides and fungicides
06/27/2001EP0733046B1 benzoyl guanidines, their production and their use in medicaments
06/27/2001CN1301264A Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists
06/27/2001CN1300732A Process for extracting heme from animal blood
06/26/2001US6252086 4-alkenyl-and 4-alkynyloxindoles
06/26/2001US6252077 1-(N′-(arylalkylaminoalkyl) aminoisoquinolines; a new class of dopamine receptor subtype specific ligands
06/26/2001US6252072 Hydrolysis of the corresponding triazine compound
06/26/2001US6251933 Seco precursors of cyclopropylindolines and their use as prodrugs
06/26/2001US6251914 Treating cytokine mediated diseases
06/26/2001US6251907 1-(aryloxyalkyl)-4-(heteroaryl) piperazines and related compounds useful as antipsychotics and analgesics
06/26/2001US6251900 Heterocyclic compounds and antitumor agent containing the same as active ingredient
06/24/2001CA2329516A1 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
06/22/2001CA2329678A1 Ep4 receptor selective agonists in the treatment of osteoporosis
06/21/2001WO2001044239A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
06/21/2001WO2001044234A1 Substituted bisindolylmaleimides for the inhibition of cell proliferation
06/21/2001WO2001044233A1 Squarylium compound and optical recording medium containing the same
06/21/2001WO2001044232A1 Belaperidone fumarate and modifications thereof
06/21/2001WO2001044229A1 Chemokine receptor binding heterocyclic compounds
06/21/2001WO2001044228A2 Derivatives of quinazolinedione phthalimide, preparations thereof and their therapeutic uses
06/21/2001WO2001044223A1 Inhibitors of interleukin 5 gene expression
06/21/2001WO2001044208A1 4,6-substituted 2-amino-1,3,5-triazine derivatives, a method for producing same and the use thereof as herbicides and plant growth regulators
06/21/2001WO2001044201A1 Substituted imidazole neuropeptide y y5 receptor antagonists
06/21/2001WO2001044200A2 Selective neurokinin antagonists
06/21/2001WO2001044195A1 Heterocycle derivatives and drugs
06/21/2001WO2001044193A1 1,3,4-substituted piperidine analogs and uses thereof in treating addictions
06/21/2001WO2001044179A1 Novel succinate compounds, compositions and methods of use and preparation
06/21/2001WO2001044178A1 Novel urea compounds, compositions and methods of use and preparation
06/21/2001WO2001043741A1 Cytotoxic n-unsubstituted indoles and cyclopent(b)indoles and method of making and using same
06/21/2001DE19960074A1 Neues Salz von Belaperidone und dessen Modifikationen New salt of Belaperidone and its modifications
06/21/2001CA2395088A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
06/21/2001CA2395075A1 1,3,4-substituted piperidine analogs and uses thereof in treating addictions
06/21/2001CA2393825A1 Novel succinate compounds, compositions and methods of use and preparation
06/21/2001CA2393672A1 Selective neurokinin antagonists
06/21/2001CA2393358A1 Heterocycle derivatives and drugs
06/21/2001CA2393027A1 Inhibitors of interleukin 5 gene expression
06/21/2001CA2362642A1 Squarylium compounds and optical recording medium containing the same
06/20/2001EP1108720A1 Herbicidal 2-Pyrazolyl-6-Aryloxy-Pyri(mi)dines
06/20/2001EP1107959A2 Quinazoline derivatives as medicaments
06/20/2001EP1107957A1 Pyrimidine compounds
06/20/2001EP1107753A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
06/20/2001EP1107738A1 Novel pharmaceutical salt form
06/20/2001CN1300282A Pyrazole derivatives as P-38 MAP kinase inhibitors
06/20/2001CN1067419C Reactive dyestuffs their preparation and their use
06/20/2001CN1067387C 1,2,3,4-tetrahydroquinoxalindione derivative
06/20/2001CN1067386C 5-heteroarylindole derivatives as benzodiazepine receptor site agnoists and analagonists
06/19/2001USRE37234 Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses
06/19/2001US6248770 Cardiovascular disorders
06/19/2001US6248768 Prostaglandin inhibitor; antiinflammatory agents